Related Experiment Video

Updated: May 24, 2025

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

17.5K

MicroRNA dysregulation and target genes in common spinal tumors

Razieh Tavakoli Oliaee1, Majid Reza Farrokhi2, Hamid Moeeni1

  • 1Shiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Cancer Genetics
|March 2, 2025
PubMed

Insights

MicroRNAs (miRNAs) are key regulators in spinal tumor development. Dysregulated miRNAs offer potential as diagnostic and therapeutic biomarkers for personalized spinal tumor treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Spinal tumors present diagnostic and therapeutic challenges due to diverse types and complex biology.
  • MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression, acting as oncogenes or tumor suppressors.
  • miRNAs are implicated in the pathogenesis and progression of various cancers.

Purpose of the Study:

  • To review the role of miRNAs in the pathogenesis and progression of common spinal tumors.
  • To explore the potential of miRNAs as diagnostic, prognostic, and therapeutic biomarkers for spinal tumors.
  • To discuss miRNA-targeted therapies for improving patient outcomes.

Main Methods:

  • Comprehensive review of existing studies on spinal tumors.
  • Analysis of data from human and in vitro models.
  • Examination of miRNA dysregulation in ependymoma, astrocytoma, meningioma, and metastatic spinal tumors.

Main Results:

  • Several miRNAs are dysregulated in common spinal tumors.
  • Dysregulated miRNAs influence critical cellular processes like proliferation, migration, and apoptosis.
  • miRNAs show potential as biomarkers for diagnosis, prognosis, and personalized treatment.

Conclusions:

  • miRNAs play significant roles in spinal tumor pathogenesis and progression.
  • Further validation is needed to understand miRNA-mediated mechanisms and clinical translation.
  • MiRNA-targeted therapies represent a promising strategy for spinal tumor management.
Keywords:
MicroRNAsMolecular biomarkersSpinal tumorsSuppressors

More Related Videos

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

7.6K
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.2K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
3.9K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K